Clinical Research Directory
Browse clinical research sites, groups, and studies.
Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
Sponsor: Sun Yat-sen University
Summary
This study aims to assess the efficacy of methylprednisolone combined with concurrent chemoradiotherapy in treating unresectable or recurrent thymoma.
Official title: A Prospective, Single-arm Phase II Study of Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2024-11-20
Completion Date
2028-11-19
Last Updated
2024-12-12
Healthy Volunteers
No
Conditions
Interventions
Radiotherapy
Hypofractionated radiotherapy
Concurrent chemotherapy
weekly albumin-bound paclitaxel (50 mg/m²) and cisplatin (25 mg/m²)
Methylprednisolone
Methylprednisolone 2mg/kg, qd, concurrent with radiotherapy
Locations (1)
Sun yat-sen University Cancer Center
Guanzhou, Guangdong, China